Morgan Stanley’s MEDIROM Healthcare Technologies MRM Stock Holding History

Morgan Stanley’s Portfolio MRM Stock Details MRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,900	Closed	-$14K	–	7903
2022 Q1	$14K	Buy	1,900 +1,857	+4,319%	+$12.6K	﹤0.01%	7284
2021 Q4	$0	Hold	43	–	–	﹤0.01%	8053
2021 Q3	$0	Buy	+43	New	+$326	﹤0.01%	7986

Other funds holding MRM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley's MRM Position: Q2 2022 in Review

Morgan Stanley sold out of MEDIROM Healthcare Technologies (MRM) in Q2 2022, closing a stake of 1,900 shares — an estimated $14K sold.

Morgan Stanley first reported a position in MRM in Q3 2021 and held it in 3 quarters. The position peaked at $14K in Q1 2022. 1 fund tracked by Wall St. Rank holds MRM as of Q2 2022.

Morgan Stanley reported no remaining MEDIROM Healthcare Technologies position as of Q2 2022 after selling out during the quarter.
Morgan Stanley sold 1,900 MEDIROM Healthcare Technologies shares in Q2 2022, an estimated $14K.
Morgan Stanley first reported a position in MEDIROM Healthcare Technologies in Q3 2021 and held it in 3 quarters.
Morgan Stanley's MEDIROM Healthcare Technologies position peaked at $14K in Q1 2022.
1 fund tracked by Wall St. Rank held MEDIROM Healthcare Technologies as of Q2 2022.

Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.